Melinta Therapeutics, Inc. /New/

CIK 1461993 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Melinta Therapeutics, Inc. /New/.

Recent SEC filings

FiledFormAccession number
Jun 24, 2020SC TO-T/A0001193125-20-177698
Jun 12, 2020SC TO-T0001193125-20-167689
Apr 20, 20208-K0001461993-20-000019
Apr 20, 2020S-3DPOS0001461993-20-000029
Apr 20, 2020S-3DPOS0001461993-20-000033
Apr 20, 2020S-8 POS0001461993-20-000025
Apr 20, 2020S-8 POS0001461993-20-000023
Apr 20, 2020S-8 POS0001461993-20-000022
Apr 20, 2020S-8 POS0001461993-20-000021
Apr 20, 2020S-3DPOS0001461993-20-000031
Apr 20, 2020S-3DPOS0001461993-20-000034
Apr 20, 2020S-8 POS0001461993-20-000028
Apr 20, 2020S-8 POS0001461993-20-000027
Apr 20, 2020S-8 POS0001461993-20-000020
Apr 20, 2020S-8 POS0001461993-20-000026
Apr 20, 2020S-8 POS0001461993-20-000024
Apr 20, 2020S-3DPOS0001461993-20-000032
Apr 14, 20208-K0001461993-20-000002
Feb 18, 20208-K0001193125-20-038710
Feb 5, 202025-NSE0001354457-20-000061
Jan 8, 20208-K0001193125-20-003880
Dec 27, 20198-K0001193125-19-324277
Nov 12, 201910-Q0001461993-19-000059
Nov 6, 20198-K0001461993-19-000054
Oct 25, 201930001461993-19-000051